As we pave the way for better patient outcomes with the first minimally invasive microbiome-driven liquid biopsy technology, we also want to make sure that the important economic benefits that health insurance companies will reap from covering early cancer detection...
While having generated a lot of buzz recently, early screening for multiple types of cancer at once may not be that ideal in practice- the path to clinical adoption could be taking on one cancer type at a time. In a perfect world, a simple blood test would catch all...
